ATE214278T1 - Verfahren und medikament zum vermindern des jet- lags - Google Patents

Verfahren und medikament zum vermindern des jet- lags

Info

Publication number: ATE214278T1
Authority: AT; Austria
Prior art keywords: medication; jet lag; reducing jet; upheavals; reducing
Prior art date: 1994-07-01

Application number

AT95924757T

Other languages

English (en)

Inventor

Bonnie Davis

Original Assignee

Bonnie Davis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-01

Filing date

1995-06-30

Publication date

2002-03-15

1995-06-30 Application filed by Bonnie Davis filed Critical Bonnie Davis

2002-03-15 Application granted granted Critical

2002-03-15 Publication of ATE214278T1 publication Critical patent/ATE214278T1/de

Links

229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 abstract 2
HPOIPOPJGBKXIR-UHFFFAOYSA-N 3,6-dimethoxy-10-methyl-galantham-1-ene Natural products O1C(C(=CC=2)OC)=C3C=2CN(C)CCC23C1CC(OC)C=C2 HPOIPOPJGBKXIR-UHFFFAOYSA-N 0.000 abstract 1
LPCKPBWOSNVCEL-UHFFFAOYSA-N Chlidanthine Natural products O1C(C(=CC=2)O)=C3C=2CN(C)CCC23C1CC(OC)C=C2 LPCKPBWOSNVCEL-UHFFFAOYSA-N 0.000 abstract 1
208000019888 Circadian rhythm sleep disease Diseases 0.000 abstract 1
208000001456 Jet Lag Syndrome Diseases 0.000 abstract 1
229960003980 galantamine Drugs 0.000 abstract 1
BGLNUNCBNALFOZ-WMLDXEAASA-N galanthamine Natural products COc1ccc2CCCC[C@@]34C=CCC[C@@H]3Oc1c24 BGLNUNCBNALFOZ-WMLDXEAASA-N 0.000 abstract 1
ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 abstract 1
208000033915 jet lag type circadian rhythm sleep disease Diseases 0.000 abstract 1
IYVSXSLYJLAZAT-NOLJZWGESA-N lycoramine Natural products CN1CC[C@@]23CC[C@H](O)C[C@@H]2Oc4cccc(C1)c34 IYVSXSLYJLAZAT-NOLJZWGESA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT95924757T 1994-07-01 1995-06-30 Verfahren und medikament zum vermindern des jet- lags ATE214278T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/269,821 US5585375A (en)	1994-07-01	1994-07-01	Method for alleviating jet lag
PCT/US1995/008219 WO1996001113A1 (en)	1994-07-01	1995-06-30	Method and medicine for alleviating jet lag

Publications (1)

Publication Number	Publication Date
ATE214278T1 true ATE214278T1 (de)	2002-03-15

Family

ID=23028794

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95924757T ATE214278T1 (de)	1994-07-01	1995-06-30	Verfahren und medikament zum vermindern des jet- lags

Country Status (11)

Country	Link
US (1)	US5585375A (de)
EP (1)	EP0764025B1 (de)
JP (1)	JPH10506097A (de)
AT (1)	ATE214278T1 (de)
AU (1)	AU694247B2 (de)
CA (1)	CA2193473A1 (de)
DE (1)	DE69525841T2 (de)
DK (1)	DK0764025T3 (de)
ES (1)	ES2170799T3 (de)
PT (1)	PT764025E (de)
WO (1)	WO1996001113A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000030446A1 (en) *	1998-11-23	2000-06-02	Bonnie Davis	Dosage formulations for acetylcholinesterase inhibitors
AU2004242546B2 (en) *	1998-11-23	2008-05-15	Bonnie Davis	Dosage formulations for acetylcholinesterase inhibitors
EP1150695B1 (de) *	1999-01-11	2007-02-28	Atanas Russinov Djananov	Nahrungszusatz aus kräutern zur steigerung der muskulären kraft und ausdauer von athleten
US8603546B2 (en) *	1999-01-11	2013-12-10	Herbaceuticals Inc.	Herbal supplement for increased muscle strength and endurance for athletes
WO2005016327A2 (en) *	2003-08-13	2005-02-24	Janssen Pharmaceutica, N.V.	Treatment of sleep disorders with cholinesterase inhibitors
WO2005065662A1 (en) *	2003-12-31	2005-07-21	Actavis Group Hf	Solid dosage formulations of galantamine
CA2551946A1 (en) *	2003-12-31	2005-07-21	Actavis Group Hf	Immediate, controlled and sustained release formulations of galantamine
EP3628315A1 (de)	2018-09-28	2020-04-01	Université de Caen Normandie	Kombination aus acetylcholinesterase-inhibitor und 5-ht4-rezeptoragonist als neuroprotektives mittel zur behandlung von neurodegenerativen krankheiten

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0584185B1 (de) *	1991-05-14	1999-08-11	Ernir Snorrason	Behandlung des ermüdungssyndroms mit cholinesteraseinhibitoren

1994
- 1994-07-01 US US08/269,821 patent/US5585375A/en not_active Expired - Lifetime
1995
- 1995-06-30 CA CA002193473A patent/CA2193473A1/en not_active Abandoned
- 1995-06-30 JP JP8503924A patent/JPH10506097A/ja not_active Ceased
- 1995-06-30 AU AU29144/95A patent/AU694247B2/en not_active Ceased
- 1995-06-30 AT AT95924757T patent/ATE214278T1/de not_active IP Right Cessation
- 1995-06-30 DE DE69525841T patent/DE69525841T2/de not_active Expired - Fee Related
- 1995-06-30 WO PCT/US1995/008219 patent/WO1996001113A1/en not_active Ceased
- 1995-06-30 EP EP95924757A patent/EP0764025B1/de not_active Expired - Lifetime
- 1995-06-30 ES ES95924757T patent/ES2170799T3/es not_active Expired - Lifetime
- 1995-06-30 DK DK95924757T patent/DK0764025T3/da active
- 1995-06-30 PT PT95924757T patent/PT764025E/pt unknown

Also Published As

Publication number	Publication date
DK0764025T3 (da)	2002-05-21
DE69525841D1 (de)	2002-04-18
AU694247B2 (en)	1998-07-16
CA2193473A1 (en)	1996-01-18
EP0764025B1 (de)	2002-03-13
US5585375A (en)	1996-12-17
ES2170799T3 (es)	2002-08-16
PT764025E (pt)	2002-07-31
EP0764025A1 (de)	1997-03-26
EP0764025A4 (de)	1999-06-02
JPH10506097A (ja)	1998-06-16
AU2914495A (en)	1996-01-25
DE69525841T2 (de)	2002-10-24
WO1996001113A1 (en)	1996-01-18

Similar Documents

Publication	Publication Date	Title
GR3033084T3 (en)	2000-08-31	Dosage forms and method for ameliorating male erectile dysfunction
EP0266149A3 (en)	1989-08-30	High wear-resistant member, method of producing the same, and valve gear using the same for use in internal combustion engine
IT1261949B (it)	1996-06-04	Composizione terapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo.
DE69529173D1 (de)	2003-01-23	Heterozyklische bizykeln zur behandlung von impotenz
ZA896681B (en)	1990-06-27	A composition for the treatment of erectile dysfunction
IL132293A0 (en)	2001-03-19	Use of lactoferin in the treatment of allergen induced disorders
FI972205A7 (fi)	1997-05-23	cGmp-PDE:n estäjiä erektiohäiriön hoidossa
NZ504026A (en)	2002-12-20	Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
NO963742D0 (no)	1996-09-06	Fremgangsmåte til å stimulere hematopoese med hemaglobin
FI881637A7 (fi)	1988-10-10	Laite kerrostumien muodostumisen estämiseksi tai vähentämiseksi moottoreiden seoskäsittelyjärjestelmissä.
PT880350E (pt)	2002-04-29	Tratamento de esclerose multipla
MY106528A (en)	1995-06-30	Method of treating impotence.
ATE214278T1 (de)	2002-03-15	Verfahren und medikament zum vermindern des jet- lags
HU9303558D0 (en)	1994-04-28	Inoculation device of improved safety suitable for use of people of poor eyesight for inoculating through the skin without a needle
EP0411282A3 (en)	1991-07-31	Use of precipitation hardening ferritic-perlitic steels as material for valves of combustion engines
EP0362847A3 (de)	1991-03-27	Verwendung von Etoperidon zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von männlicher Impotenz
WO1999065475A3 (en)	2000-04-06	Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
EP0758656A3 (de)	1997-08-06	Immunoglobuline die durch Mischung mit einem Komponenten von Histamin aktiviert wurden
PT862454E (pt)	2002-11-29	Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados
ZA912204B (en)	1991-12-24	Method for the study of internal body tissues
IT1278144B1 (it)	1997-11-17	Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo.
DE68910010D1 (de)	1993-11-25	Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin.
UA26939C2 (uk)	1999-12-29	Засіб для лікуваhhя аутоімуhhих захворюваhь і спосіб їх лікуваhhя
ITMI922766A1 (it)	1994-06-03	Impiego di lisolecitine nel trattamento della impotenza maschile e dell'alopecia e relative composizioni atte a tale impiego.
EP0459055A3 (en)	1992-05-27	Letterpress for transferring and method of transferring by use of the letterpress for transferring

Legal Events

Date	Code	Title	Description
2005-03-15	REN	Ceased due to non-payment of the annual fee